Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
GlobalData on MSN15h
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
BioPharma Dive20h
Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
MBK Partners-Led Consortium Acquires Japanese Semiconductor Company FICT In $660 Million Deal
The North Asian private equity giant cited rising demand for semiconductor products amid the AI boom for its decision to ...
China Investment Map Shows Expansion Into New Counties Amid USAID Upheaval
Supporters of the move believe USAID was poorly managed and wasting taxpayers' money, with White House Press Secretary ...
US equities fall as hopes for lower rates fade again
Moderating job growth, rising inflation expectations and the prospect of reciprocal tariffs knocked the wind out of Wall ...
investmentmagazine4h
NWQ appoints hedgie veteran to advisory role
NWQ Capital Management, a boutique alternatives firm based in Perth, has appointed a celebrated supporter of Australian hedge funds as an adviser. (more…) Product innovation in post-retirement is ...